S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
How to Invest in AI's Fast-Growing Market (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Is There Still Time to Get In On the Lithium Boom? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Is There Still Time to Get In On the Lithium Boom? (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
How to Invest in AI's Fast-Growing Market (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Is There Still Time to Get In On the Lithium Boom? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Is There Still Time to Get In On the Lithium Boom? (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
How to Invest in AI's Fast-Growing Market (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Is There Still Time to Get In On the Lithium Boom? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Is There Still Time to Get In On the Lithium Boom? (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
How to Invest in AI's Fast-Growing Market (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Is There Still Time to Get In On the Lithium Boom? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Is There Still Time to Get In On the Lithium Boom? (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
CVE:HVT

Harvest One Cannabis (HVT) Competitors

C$0.02
0.00 (0.00%)
(As of 09/7/2022)
Compare
Today's Range
C$0.03
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.03
C$0.09
Volume
5,235 shs
Average Volume
126,267 shs
Market Capitalization
C$6.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HVT vs. NDVA, LBL, DN, EVE, KHRN, AQS, ASP, FLWR, NU, and AH

Should you be buying Harvest One Cannabis stock or one of its competitors? The main competitors of Harvest One Cannabis include Indiva (NDVA), Lattice Biologics (LBL), Delta 9 Cannabis (DN), Eve & Co Incorporated (EVE), Khiron Life Sciences (KHRN), Aequus Pharmaceuticals (AQS), Acerus Pharmaceuticals (ASP), Flowr (FLWR), NeutriSci International (NU), and Aleafia Health (AH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Harvest One Cannabis vs.

Indiva (CVE:NDVA) and Harvest One Cannabis (CVE:HVT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk.

0.4% of Indiva shares are held by institutional investors. 26.1% of Indiva shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Harvest One Cannabis has a net margin of 0.00% compared to Indiva's net margin of -28.94%. Harvest One Cannabis' return on equity of 0.00% beat Indiva's return on equity.

Company Net Margins Return on Equity Return on Assets
Indiva -28.94% -215.12% -8.39%
Harvest One Cannabis N/A N/A N/A

In the previous week, Indiva had 2 more articles in the media than Harvest One Cannabis. MarketBeat recorded 2 mentions for Indiva and 0 mentions for Harvest One Cannabis. Indiva's average media sentiment score of 0.72 beat Harvest One Cannabis' score of 0.00 indicating that Indiva is being referred to more favorably in the media.

Company Overall Sentiment
Indiva Positive
Harvest One Cannabis Neutral

Indiva and Harvest One Cannabis both received 59 outperform votes by MarketBeat users. However, 78.67% of users gave Indiva an outperform vote while only 61.46% of users gave Harvest One Cannabis an outperform vote.

CompanyUnderperformOutperform
IndivaOutperform Votes
59
78.67%
Underperform Votes
16
21.33%
Harvest One CannabisOutperform Votes
59
61.46%
Underperform Votes
37
38.54%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Indiva
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Harvest One Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Indiva has higher revenue and earnings than Harvest One Cannabis. Indiva is trading at a lower price-to-earnings ratio than Harvest One Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IndivaC$34.94 million0.19-C$10.11 million-C$0.08-0.56
Harvest One CannabisC$8.39 million0.75-C$13.64 million-C$0.05-0.46

Summary

Indiva beats Harvest One Cannabis on 7 of the 13 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of CVE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HVT vs. The Competition

MetricHarvest One CannabisDrug Manufacturers IndustryMedical SectorCVE Exchange
Market CapC$6.32MC$1.38BC$4.54BC$64.47M
Dividend YieldN/A1.73%5.98%14.03%
P/E Ratio-0.4668.7486.9217.76
Price / Sales0.7521,246.413,488.57889.46
Price / Cash3.5710.1122.2430.80
Price / Book1.143.364.665.39
Net Income-C$13.64M-C$50.18MC$116.62M-C$6.04M
7 Day PerformanceN/A2.41%2.81%1.25%
1 Month PerformanceN/A-4.02%1.05%-1.83%
1 Year PerformanceN/A-16.53%14.27%-5.71%

Harvest One Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NDVA
Indiva
0 of 5 stars
C$0.05
-16.7%
N/A-78.0%C$7.44MC$34.94M-0.63147,000High Trading Volume
LBL
Lattice Biologics
0 of 5 stars
C$0.04
flat
N/A+0.0%C$5.13MC$1.56M-4.44N/A
DN
Delta 9 Cannabis
0 of 5 stars
C$0.06
flat
N/A-77.6%C$8.90MC$67.65M-0.25210
EVE
Eve & Co Incorporated
0 of 5 stars
C$0.10
-4.8%
N/A+0.0%C$3.68MC$6.36M-0.492,021Gap Down
KHRN
Khiron Life Sciences
0 of 5 stars
C$0.04
flat
C$0.45
+1,025.0%
-70.4%C$9.30MC$16.14M-0.24N/AGap Up
AQS
Aequus Pharmaceuticals
0 of 5 stars
C$0.03
-16.7%
N/A-42.9%C$3.32MC$1.38M-1.2510Gap Down
ASP
Acerus Pharmaceuticals
0 of 5 stars
N/AN/AN/AC$2.78MC$3.04M-0.0814
FLWR
Flowr
0 of 5 stars
C$0.03
flat
N/A-16.7%C$10.66MC$12.92M-0.12186
NU
NeutriSci International
0 of 5 stars
C$0.01
+100.0%
N/A-60.0%C$1.78MC$432,451.00-2.50147,000Gap Up
AH
Aleafia Health
0 of 5 stars
C$0.03
flat
C$0.10
+233.3%
N/AC$12.10MC$38.49M-0.03N/AHigh Trading Volume

Related Companies and Tools

This page (CVE:HVT) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -